Journey Advisory Group’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-261
Closed -$278K 283
2024
Q4
$278K Sell
261
-2,349
-90% -$178K 0.03% 195
2024
Q3
$278K Sell
2,610
-100
-4% -$8.69K 0.03% 195
2024
Q2
$289K Buy
2,710
+260
+11% +$24.9K 0.03% 193
2024
Q1
$238K Buy
+2,450
New +$216K 0.03% 215
2023
Q1
Sell
-12,750
Closed -$536K 241
2022
Q4
$536K Sell
12,750
-11,980
-48% -$501K 0.13% 125
2022
Q3
$905K Sell
24,730
-6,290
-20% -$280K 0.23% 91
2022
Q2
$1.56M Buy
31,020
+3,930
+15% +$187K 0.36% 66
2022
Q1
$1.46M Buy
27,090
+14,770
+120% +$860K 0.37% 65
2021
Q4
$886K Sell
12,320
-470
-4% -$29.5K 0.24% 90
2021
Q3
$728K Buy
12,790
+3,250
+34% +$198K 0.24% 95
2021
Q2
$621K Buy
9,540
+1,330
+16% +$84K 0.2% 102
2021
Q1
$489K Buy
+8,210
New +$447K 0.17% 109

Other funds holding LRCX

Journey Advisory Group's LRCX Position: Q1 2025 in Review

Journey Advisory Group sold out of Lam Research (LRCX) in Q1 2025, closing a stake of 261 shares — an estimated $278K sold.

Journey Advisory Group first reported a position in LRCX in Q1 2021 and held it in 12 quarters. The position peaked at $1.56M in Q2 2022. 1,796 funds tracked by Wall St. Rank hold LRCX as of Q1 2025.

  • Journey Advisory Group reported no remaining Lam Research position as of Q1 2025 after selling out during the quarter.
  • Journey Advisory Group sold 261 Lam Research shares in Q1 2025, an estimated $278K.
  • Journey Advisory Group first reported a position in Lam Research in Q1 2021 and held it in 12 quarters.
  • Journey Advisory Group's Lam Research position peaked at $1.56M in Q2 2022.
  • 1,796 funds tracked by Wall St. Rank held Lam Research as of Q1 2025.

Based on Journey Advisory Group's 13F filing for Q1 2025, filed 13 May 2025.